LAMA
LAMA is a pharmaceutical drug with 7 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 7 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
5
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
7 of 7 finished
0.0%
0 ended early
0
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - Salbutamol vs Long-acting Muscarinic Antagonists
Effects of Acute Long-acting Bronchodilation on Oxygenation and Peripheral Ventilation in COPD
A Study in Taiwan Based on Medical Records That Looks at the Occurrence of Flare-ups in Patients With Chronic Obstructive Pulmonary Disease (COPD) Who Started LABA/LAMA or LAMA Treatment
INTREPID: Investigation of TRELEGY Effectiveness: Usual Practice Design
Longitudinal Cohort Study in Participants With Severe Asthma to Assess Biomarkers
Clinical Trials (7)
Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - Salbutamol vs Long-acting Muscarinic Antagonists
Effects of Acute Long-acting Bronchodilation on Oxygenation and Peripheral Ventilation in COPD
A Study in Taiwan Based on Medical Records That Looks at the Occurrence of Flare-ups in Patients With Chronic Obstructive Pulmonary Disease (COPD) Who Started LABA/LAMA or LAMA Treatment
INTREPID: Investigation of TRELEGY Effectiveness: Usual Practice Design
Longitudinal Cohort Study in Participants With Severe Asthma to Assess Biomarkers
Study to Evaluate the Efficacy and Safety of Glycopyrronium or Indacaterol Maleate and Glycopyrronium Bromide Fixed-dose Combination Regarding Symptoms and Health Status in Patients With Moderate COPD Switching From Treatment With Any Standard COPD Regimen
Effect of a New Combination Bronchodilator on Exercise in GOLD Stage II Moderate COPD
All 7 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 7